🇺🇸 Boostrix IPV infant acellular Pertussis in United States

Boostrix IPV infant acellular Pertussis (Boostrix IPV infant acellular Pertussis) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Boostrix IPV infant acellular Pertussis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Boostrix IPV infant acellular Pertussis approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Boostrix IPV infant acellular Pertussis in United States?

London School of Hygiene and Tropical Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.